Johnson & Johnson (JNJ) Net Income - Minority (2010)

Johnson & Johnson's (JNJ) quarterly Net Income - Minority came in at -$590.0 million in Q1 2010.

Johnson & Johnson (JNJ) Net Income - Minority (2010) Analysis & Trends

Johnson & Johnson has disclosed Net Income - Minority across 1 years of filings, most recently posting -$590.0 million for Q1 2010.

Net Income - Minority for Q1 2010 came in at -$590.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2010 was -$590.0 million (changed N/A YoY), and the FY2010 annual result was -$590.0 million, changed N/A from the prior year.
Net Income - Minority came in at -$590.0 million for Q1 2010 at Johnson & Johnson.
In the past five years, Net Income - Minority ranged from a high of -$590.0 million in Q1 2010 to a low of -$590.0 million in Q1 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income - Minority (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn	-
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn	-
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn	-
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn	-
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn	-
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn	-
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn	-
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn	-
10	Novartis Ag	108.28 Bn	107.60 Bn	-	-

Download Data

Date	Value
Jan 3, 2010	-590.00 Mn